CN103478820A - Eucommia male flower beverage - Google Patents
Eucommia male flower beverage Download PDFInfo
- Publication number
- CN103478820A CN103478820A CN201310468954.0A CN201310468954A CN103478820A CN 103478820 A CN103478820 A CN 103478820A CN 201310468954 A CN201310468954 A CN 201310468954A CN 103478820 A CN103478820 A CN 103478820A
- Authority
- CN
- China
- Prior art keywords
- male flower
- eucommia bark
- bark male
- mulberry leaf
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000208688 Eucommia Species 0.000 title claims abstract description 119
- 235000013361 beverage Nutrition 0.000 title claims abstract description 74
- 240000000249 Morus alba Species 0.000 claims abstract description 110
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 110
- 241001092040 Crataegus Species 0.000 claims abstract description 70
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 70
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 70
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 70
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 70
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 70
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 70
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 70
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 70
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 70
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 70
- 235000019202 steviosides Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 11
- 235000000346 sugar Nutrition 0.000 claims abstract description 9
- 241001570521 Lonicera periclymenum Species 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 35
- 239000000284 extract Substances 0.000 claims description 28
- 238000005303 weighing Methods 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 25
- 239000008213 purified water Substances 0.000 claims description 15
- 238000009835 boiling Methods 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000004383 Steviol glycoside Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 229930182488 steviol glycoside Natural products 0.000 claims description 13
- 235000019411 steviol glycoside Nutrition 0.000 claims description 13
- 150000008144 steviol glycosides Chemical class 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- 229930006000 Sucrose Natural products 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 8
- 241000245240 Lonicera Species 0.000 claims description 5
- 230000006870 function Effects 0.000 abstract description 26
- 230000036541 health Effects 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 10
- 235000013305 food Nutrition 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 238000005728 strengthening Methods 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000004438 eyesight Effects 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 229940013618 stevioside Drugs 0.000 abstract 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 abstract 1
- 230000001131 transforming effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 40
- 230000036039 immunity Effects 0.000 description 26
- 206010016256 fatigue Diseases 0.000 description 19
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 230000002929 anti-fatigue Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000012856 packing Methods 0.000 description 8
- 235000005875 quercetin Nutrition 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- 229930013930 alkaloid Natural products 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 230000002218 hypoglycaemic effect Effects 0.000 description 7
- -1 oxygen radical Chemical class 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 6
- 150000003797 alkaloid derivatives Chemical class 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 229930003935 flavonoid Natural products 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 235000017173 flavonoids Nutrition 0.000 description 6
- 238000003304 gavage Methods 0.000 description 6
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 6
- 229960001285 quercetin Drugs 0.000 description 6
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 5
- 229930003944 flavone Natural products 0.000 description 5
- 235000011949 flavones Nutrition 0.000 description 5
- 244000237330 gutta percha tree Species 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 5
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 5
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 5
- 235000005493 rutin Nutrition 0.000 description 5
- 229960004555 rutoside Drugs 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 4
- 229940074393 chlorogenic acid Drugs 0.000 description 4
- 235000001368 chlorogenic acid Nutrition 0.000 description 4
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 4
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 150000002213 flavones Chemical class 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- YZNNBIPIQWYLDM-HSUXUTPPSA-N Fagomine Chemical compound OC[C@H]1NCC[C@@H](O)[C@@H]1O YZNNBIPIQWYLDM-HSUXUTPPSA-N 0.000 description 3
- YZNNBIPIQWYLDM-ZLUOBGJFSA-N Fagomine Natural products OC[C@@H]1NCC[C@H](O)[C@H]1O YZNNBIPIQWYLDM-ZLUOBGJFSA-N 0.000 description 3
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 3
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- YZNNBIPIQWYLDM-UHFFFAOYSA-N L-fagomine Natural products OCC1NCCC(O)C1O YZNNBIPIQWYLDM-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000009661 fatigue test Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 208000033065 inborn errors of immunity Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000009916 joint effect Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 2
- ZJDOESGVOWAULF-OGJQONSISA-N Geniposidic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=CC[C@@H]2C(C(O)=O)=CO1 ZJDOESGVOWAULF-OGJQONSISA-N 0.000 description 2
- VYAALAFRWREWLA-BVTMAQQCSA-N Geniposidic acid Natural products CCC1=CC[C@H]2[C@@H]1[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C2C(=O)O VYAALAFRWREWLA-BVTMAQQCSA-N 0.000 description 2
- ZJDOESGVOWAULF-UHFFFAOYSA-N Geniposidinsaeure Natural products OC1C(O)C(O)C(CO)OC1OC1C2C(CO)=CCC2C(C(O)=O)=CO1 ZJDOESGVOWAULF-UHFFFAOYSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061216 Infarction Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- BZPMXJKRKXDRID-UOIKKKDVSA-N Scandoside Natural products OC[C@H]1O[C@@H](O[C@H]2CC=C([C@@H]3[C@@H](O)C=C(CO)[C@H]23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O BZPMXJKRKXDRID-UOIKKKDVSA-N 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 2
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 2
- 230000001363 autoimmune Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000007574 infarction Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229930015704 phenylpropanoid Natural products 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010065369 Burnout syndrome Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000573199 Homo sapiens Protein PML Proteins 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ATKYNAZQGVYHIB-IXXDHKBRSA-N Norhyoscyamine Natural products C1([C@@H](C(=O)OC2C[C@H]3CC[C@H](N3)C2)CO)=CC=CC=C1 ATKYNAZQGVYHIB-IXXDHKBRSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 240000007930 Oxalis acetosella Species 0.000 description 1
- 235000008098 Oxalis acetosella Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000010240 Paullinia pinnata Nutrition 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- ATKYNAZQGVYHIB-IZGVIRRGSA-N [(1r,5s)-8-azabicyclo[3.2.1]octan-3-yl] (2s)-3-hydroxy-2-phenylpropanoate Chemical compound C1([C@H](C(=O)OC2C[C@H]3CC[C@H](N3)C2)CO)=CC=CC=C1 ATKYNAZQGVYHIB-IZGVIRRGSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 102000054896 human PML Human genes 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229940126707 lipid peroxidation inhibitor Drugs 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- BGMYHTUCJVZIRP-GASJEMHNSA-N nojirimycin Chemical class OC[C@H]1NC(O)[C@H](O)[C@@H](O)[C@@H]1O BGMYHTUCJVZIRP-GASJEMHNSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004938 stress stimulation Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- ATKYNAZQGVYHIB-UHFFFAOYSA-N tropaic acid nortropanyl ester Natural products C1C(N2)CCC2CC1OC(=O)C(CO)C1=CC=CC=C1 ATKYNAZQGVYHIB-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
An eucommia male flower beverage comprises the following raw materials by weight: 4-6 parts of eucommia male flower, 6-8 parts of honeysuckle, 6-8 parts of mulberry leaves and 3-5 parts of hawthorn; the eucommia flower drink is added with 0.3-0.4 part of stevioside, so as to prepare a sugar-free eucommia male flower beverage, or the eucommia flower drink is added with white granulated sugar accounting for 5-7 wt% of the total weight of eucommia male, honeysuckle, mulberry leaf and hawthorn, so as to obtain sugar-containing eucommia male flower beverage. Combination of the four components in the eucommia male flower beverage provided by the invention realizes compound synergism; liver and kidney nourishing efficacy of eucommia male flower, food retention removing, stagnation transforming, spleen invigorating and stomach strengthening efficacies of hawthorn, and the wind dispelling, heat clearing, liver clearing and eyesight improving efficacies of mulberry leaf are complementary, so as to realize more outstanding health care functions.
Description
Technical field
The present invention relates to beverage, be specifically related to a kind of eucommia Bark male flower beverage anti-ageing, fatigue-resisting function that has.
Background technology
Along with developing rapidly of modern society, people not only will bear the multiple pressure of the each side such as study, work, life, and, because environmental pollution is day by day serious, many people are in " inferior health " state, and main manifestations is that immunity of organisms descends, susceptible fatigue etc.Medical research shows, the mankind 99% disease is all relevant with immune system, therefore, wants prophylactic generation, the physique of keeping fit, and it is crucial improving immunity.Often the crowd's body immune system function under fatigue state can constantly go down simultaneously, and how alleviating and eliminating fatigue also becomes the major issue that improves immunity.
Modern immunology thinks, immunity is body identification and removes nonself macromolecular complex, and the physiological reaction of holder internal and external equilibrium, i.e. a kind of process of body to the identification of " non-oneself " material, eliminating, elimination.The immunologic function of human body is one defence line, is escorting health; Be again a kind of ability of getting rid of illness, after the people is ill, can promote rehabilitation, this just becomes human body and keeps fit disease-resistant basic place.Yet, in daily life, have many factors body immunity is descended or immunologic derangement occurs.Such as, meals are unreasonable, protein, vitamin, micro-insufficiency of intake; Live irregular, do not have enough sleep; The exercise that lacks exercise, poor to the adaptive capacity of environment; Stress, overworked; Use the bad reaction of hormone, antibiotic etc, suppressed immunity; Temporarily reduced immunity while suffering from acute disease, while suffering from chronic diseases for a long time in hypoimmunity state etc.
Fatigue is also one of the principal element of 21 century harm humans health.At society, because rhythm of life is accelerated, a lot of people are bearing larger psychological pressure or for a long time in overtime excess load work state, as unreasonable rest, adjusting, if things go on like this, the vitals function of health will be lacked of proper care, thereby causes the generation of a series of fatigue symptoms such as burnout, giddy, headache, limbs fatigue, listless, failure of memory.Fatigue can cause that oxygen radical gathers, immunologic hypofunction etc., if eliminate not in time, disease will be comed one after another in the course of time, has a strong impact on people's work and life.According to World Health Organization investigation, approximately there is people more than 35% in the whole world in fatigue state, and especially middle-aged male crowd fatigue state person is up to 60%-75%.The medical expert points out, continues overtiredly can cause a series of ill symptomses, produces " burnout syndrome ".
If long-time hypoimmunity or, in fatigue state, human body just there will be the intermediateness-sub-health state of healthy and disease.And sub-health state is continuous Change and Development, as do not improved in time, probably to morbid state, transform.So, improve human body autoimmune function, alleviating physical fatigue, be away from inferior health, move towards healthy basic method.The relevant survey data of China shows, crowd more than 60% arranged in sub-health status, only relies on the medicine symptomatic treatment to be difficult to return to the normal health state.And the center of gravity of modern medicine turns to the intervention of state before sick and effective strick precaution of disease, traditional Chinese medicine shows unique characteristics in the adjustment to the animal economy functional status, take to have the health food that the Chinese medicine that improves immunity and alleviating physical fatigue function is raw material potential advantage is arranged.
The health food with enhancing immunity and alleviating physical fatigue of selling in the market is more, mainly with individual event enhancing immunity or individual event alleviating physical fatigue, be main, but hypoimmunity and fatiguability interknits.The imbalance of human body autoimmune function, immunity degradation there will be the sub-health states such as physical fatigue, and can cause immunity degradation in fatigue state for a long time.
Although some folium cortex eucommiaes, bark of eucommia jasmine tea etc. have occurred at present, its component is too simple, poor effect, and adopt the form of tealeaves to exist, when soaking, active ingredient can not be soaked out fully, causes the waste of active ingredient.Therefore a kind of antifatigue of necessary exploitation, to strengthen the immunity effect more outstanding, and the beneficiating ingredient of the bark of eucommia is utilized to health products more fully.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of eucommia Bark male flower beverage, and it has the immunity of enhancing and alleviating physical fatigue double action, thereby eliminates defect in the above-mentioned background technology.
For solving the problems of the technologies described above, technical scheme of the present invention is:
A kind of eucommia Bark male flower beverage comprises the raw material of following weight portion:
As a kind of improvement, add steviol glycoside 0.3~0.4 weight portion in described eucommia Bark male flower beverage, thereby prepare Sugarless type eucommia Bark male flower beverage.
As a kind of improvement, add white granulated sugar in described eucommia Bark male flower beverage, 5wt%~7wt% that described white sugar content is eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, thus make sugar-containing type eucommia Bark male flower beverage.
As a kind of improvement, described eucommia Bark male flower beverage is preferably the raw material of following weight portion:
The preparation method of Sugarless type eucommia Bark male flower beverage of the present invention is as follows:
S1, weighing 4~6 weight portion eucommia Bark male flowers, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 6~8 weight portion honeysuckles, 6~8 weight portion mulberry leaf and 3~5 weight portion hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein steviol glycoside 0.3~0.4 weight portion to stir evenly, add purified water to gross weight 1000 weight portions.
Of the present invention have the preparation method of sugared type eucommia Bark male flower beverage as follows:
S1, weighing 4~6 weight portion eucommia Bark male flowers, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 6~8 weight portion honeysuckles, 6~8 weight portion mulberry leaf and 3~5 weight portion hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then adds wherein 5wt%~7wt% that white granulated sugar, described white sugar content are eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight,, add purified water to gross weight 1000 weight portions.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain the eucommia Bark male flower beverage.
In the present invention, the male flower pistil that eucommia Bark male flower is the bark of eucommia (the male tree of bark of eucommia genitals).The bark of eucommia is Chinese famous and precious tonic herb.Tool filling liver kidney, strengthening the bones and muscles, many effects such as hypotensive, antiabortive.Shennong's Herbal is classified as top grade.And eucommia Bark male flower, contain lignin, iridoids, Phenylpropanoid Glycosides class active skull cap components (as Geniposidic acid, chlorogenic acid, Aucubin), rosin spirit disaccharide glucoside, flavones (Quercetin), amino acid, polysaccharide and mineral element Zn, Mn, Cu, Fe, Ca, P, B, Mg, K etc.Wherein amino acid content reaches 21.47%, and the content of calcium reaches 0.92%, and zinc content reaches 51mg/100g.General flavone content in eucommia Bark male flower is 5-7.3 times of Bark of Eucommia Ulmoides, and chlorogenic acid content is 2.7-4 times of Bark of Eucommia Ulmoides; Several Major constituent contents such as calcium, phosphorus, potassium, sodium, magnesium are 2.3 times of Bark of Eucommia Ulmoides, and iron, zinc, copper, manganese, selenium and other trace elements content are 7.1 times of Bark of Eucommia Ulmoides; 10 seed amino acid content of needed by human reach 9.69g/100g, are 4.82 times of Bark of Eucommia Ulmoides, and in eucommia Bark male flower, the essential amino acid proportioning almost approaches or exceeds the mode standard value that FAO/WHO recommends, and is rare healthy treasure.Scientific research is found: " eucommia Bark male flower " is special containing the effective plant component of kind more than 60, as lignin, iridoids, Phenylpropanoid Glycosides class active material is (as Geniposidic acid, chlorogenic acid, Aucubin), rosin spirit disaccharide glucoside, flavones, alkaloid, amino acid, polysaccharide and mineral element Zn, Mn, Cu, Fe, Ca, P, B, Mg, K etc., wherein amino acid content reaches 21.47%, the content of calcium reaches 0.92%, zinc content reaches 51mg/100g, respectively 1.8 times and 5.2 times of folium cortex eucommiae, active ingredient is the most comprehensive, and content is higher, eucommia Bark male flower, the elite of having collected all barks of eucommia, can say that eucommia Bark male flower possesses all health-care efficacies of the plant bark of eucommia, and for " strong liver, kidney tonifying, defaecation, sleep peacefully, three height fall " effect particularly remarkable.Modern pharmacological research shows, the water decoction increase phagocyte activity of eucommia Bark male flower, and the non-specific immune function of enhancing body, have dual regulation to cellular immune function.
Mulberry leaf in the present invention are one of China's conventional medicaments, belong to the medicine-food two-purpose article.In recent years, the various countries scholar has carried out large quantity research to mulberry leaf, and especially Japan, from nineteen ninety, has started " exploitation does not utilize food material " research project, and mulberry leaf function and process technology thereof are conducted in-depth research.The a lot of experts of China have also carried out the research of chemical composition and pharmacologically active aspect, find that mulberry leaf nutrient is worth very high, contain various bioactivators.In recent years, mulberry leaf exploitation heat has been risen in Japan, Korea S, and its people have been risen the upsurge of one edible mulberry leaf.China has also started the exploitation of mulberry leaf products, utilize at present the food of mulberry leaf development a lot, comprise bread and cheese, health food, beverage, flavouring etc., the product of having developed has Mulberry-leaf Tea (6g/ day), mulberry leaf powder, and (a kind of is that former mulberry leaf are pulverized for end, by 200 mesh sieves; Another kind is the mulberry leaf extracts) and mulberry leaf juice beverage, mulberry leaf ice cream, mulberry leaf instant tea, mulberry leaf cola, mulberry leaf carbonated drink, mulberry leaf mixed congee, mulberry leaf are brilliant, mulberry leaf can take liquid, mulberry leaf pearl powder honey, mulberry leaf pollen honey, mulberry leaf dried noodles, mulberry leaf bean curd, mulberry leaf biscuit, mulberry leaf bean powder, mulberry leaf wine, mulberry leaf ham sausage, mulberry leaf vinegar, mulberry leaf sauce etc.; Also rise at present with mulberry leaf as animal feed or feed addictive, rear cattle (improving the cow milk yield), exempt from, deer, fish etc., effect is fine.Rutin sophorin in mulberry leaf, Quercetin, quercitin can increase convergent force and the output quantity of in vitro and the frog heart in place, and reduce heart rate.Rutin sophorin makes toad lower limb and rabbit ear vessel retraction, and the expansible coronary vasodilator of Quercetin improves the cardiac muscle circulation.GABA, rutin sophorin, quercitrin have hypotensive effect.Wherein alpha-aminobutyric acid content is very high, up to 226mg/100g, noticeable.GABA is the neural material of passing on, and can promote the metabolism of brain tissue and recover function of brain cell, simultaneously, can improve brain blood and flow, and strengthens the activity of Angiotensin-Converting I, impels blood pressure drops.Rutin sophorin in mulberry leaf, Quercetin, quercitin can increase convergent force and the output quantity of in vitro and the frog heart in place, and bibliographical information is arranged, and isolate the various active composition as flavones and derivative thereof from mulberry leaf, confirm the step-down of mulberry leaf energy.Mulberry leaf have the formation that suppresses fatty liver, the effect that reduces serum fat and inhibition atherogenesis.Active component comprises DNJ, phytosterol, flavonoids etc.Hyperlipidemia patient's blood viscosity is high, flowing in capillary is very not smooth, capillary very easily stops up, low-density lipoprotein (LDL-C) oxidation is the major reason that causes circulation system disease, oxidation lipoprotein is deposited on blood vessel can make lumen of vessels narrow down, even stop up, myocardial infarction and cerebral hemorrhage are all the results that capillary stops up.Contain the strengthening capillary in mulberry leaf, reduce the flavones ingredient of blood viscosity, another Mulberry-leaf Tea contains the composition of LDL-lipoprotein oxidation in antibody, so mulberry leaf have again the effect of prevention myocardial infarction and cerebral hemorrhage when fat-reducing, improving hyperlipidemia.The good generation confirmation of Japan expert soil well, the hyperlipidemia serum lipids is raise mulberry-leaf extract and atherosclerotic has inhibitory action.High ridge report, Mulberry-leaf Tea makes hyperlipidemia rats serum high-density LP (HDL-C), HDL-C/TC obviously raise (p<0.05), T-CHOL (TC), LDL-C, triacylglycerol (TG) obviously reduce (p<0.05), lipid peroxide (LPO) significantly reduces (p<0.001), illustrate that Mulberry-leaf Tea can reduce blood fat, softening blood vessel, removing body endoperoxide, thereby the rising of hyperlipidemia serum lipids and atherosclerotic are had to inhibitory action.Since ancient times, the traditional Chinese medical science just is applied to clinical using mulberry leaf as the Chinese medicine for the treatment of diabete (being the diabetes of modern medicine), and Japanese ancient book " eating tea health note " is also put down in writing the effect that mulberry leaf are improved " drinking-water is sick " (being the diabetes of modern medicine).The studying data at home and abroad confirmation, alkaloid and polysaccharide are blood sugar reducing components main in mulberry leaf.In recent years, large quantity research shows that the hypoglycemic activity of mulberry leaf realizes by two approach: the one, by alkaloid DNJ(1-DNJ) to the active generation of disaccharides catabolic enzyme inhibitory action, thereby suppress the absorption of small intestine to disaccharide, reduce the peak value of the rear blood sugar of food; The 2nd, Folium Mori alkaloid fagomine and mulberry leaf polysaccharide promote that the β cell divides must insulin, and insulin can promote cell to close sugared utilization, hepatic glycogen or and improve glycometabolism, finally reach hypoglycemic effect.Asano etc. have compared isolated 7 kinds of alkaloidal hypoglycemic activities from mulberry leaf, find that the polyhydroxy norhyoscyamine has very strong glycosidase inhibiting function; Kimura M etc. has observed the diabetic mice hypoglycemic activity that above 7 kinds of alkaloids cause STZ, experimental result shows, N-Me-DNJ, GAL-DNJ and fagomine can reduce blood sugar level significantly, wherein GAL-DNJ and fagomine hypoglycemic activity are the strongest, in plant only mulberry leaf contain this alkaloid of GAL-DNJ (this be the advantageous natural active matters of mulberry leaf, other plant is not all containing this class material in the world), it is a kind of inhibitor of glycosidase, and soluble in water, easily be absorbed by the body.Fan Lisheng found through experiments white mulberry vein-juice has good inhibition growth to most of gram positive bacterias and gram-negative bacteria and part saccharomycete.And required Mlc is low, pH value scope is 4~9, heat endurance is strong.Rutin sophorin can significantly suppress the Rat Models of Traumatic edema, and can stop the development of conjunctivitis, auricle inflammation, pulmonary edema.Mulberry leaf can prevent cancer cell to generate, and improve body immunity, and the major function composition comprises it being DNJ, flavonoids, Sang Su, SOD, GABA and vitamin, can suppress chromosome mutation and gene mutation.1-DNJ (DNJ) is a kind of alkaloid in mulberry leaf, and clinical testing proof DNJ has the effect of significant anti-reverse transcription enzymophathy cytotoxic activity, and its IG30 is 1.2-2.5 μ g/mL, and, with the increase of DNJ dosage, its restraint strengthens.Mouse β-16 lung black cell the tumour of take is model, the derivative relevant to 1-nojirimycin A and the activity of resisting tumor metastasis of analog thereof have been studied, point out that DNJ is the analogue of nojirimycin, it is 80.5% to the inhibiting rate of metastases, it suppresses mechanism: DNI produces immature carbohydrate chain by the activity that suppresses glycosidase at tumor cell surface, has weakened the transfer ability of tumour.Two kinds of flavonoids of separation and purification in the discovery mulberry leaf such as Korea scholar Kim-food in one's mouth bucket skin element-3-β-D glucopyranoside and Quercetin-3-7-dioxy-β-D-glucopyranoside reveal significant depression effect to the growth table of human promyelocytic leukemia cell (HL-60), and its latter has also induced the differentiation of HL-60 cytokine.Sang Su in mulberry leaf has active anticancer, and the vitamin in mulberry leaf has the other mutagen effect of pressing down.In mulberry leaf, the compositions such as contained Quercetin, phenolic compound, vitamin C can be by suppressing or remove free radical to prevent oxidative damage.The reports such as Huang Dong, mulberry leaf have help and the effect anti-ageing, that stablize nervous function of similar ginseng, can alleviate excited that physiological change causes, improve the activity of superoxide dismutase in body, stop the generation of harmful substance in body, reduce or eliminate the lipofuscin that produces and stagnate in body.Tang Fadi etc. adopt anti-stress, anti-fatigue test, aged rats SOD and lipofuscin are measured, and the life span of drosophila melanogaster test confirms that mulberry leaf can improve mouse to the tolerance of high temperature stimulation and prevent that the Rat Adrenal Cortex distributed function caused due to stress stimulation is low, and, when adrenal function is low, it is normal that mulberry leaf can make it to recover.With dexamethasone, make mouse produce " exhaustion ", mulberry leaf can alleviate the generation of this phenomenon.Mulberry leaf can extend mouse swimming and transfer rod time, have the body of enhancing Endurence.Mulberry leaf can extend the life-span of fruit bat, can improve SOD content in the senile rat red blood cell, thereby can effectively remove the superoxide anion that biological oxidation produces, and can reduce senile rat brain, myeloid tissue's content, show to have the effect delayed senility.DNJ. after in mineral matter and small intestine, unabsorbed carbohydrate enters large intestine, by the intestinal flora effect, cause fermentation; produce the organic acids such as butyric acid, propionic acid, lactic acid, acetic acid; make environment in intestines become acidity; intestinal contents acidity increases; the propagation that can suppress harmful bacteria; play regulating intestinal canal, improve constipation, improve the effect of belly sensation of fullness, therefore there is the catharsis defaecation, reduce the generation of some acute abdomen, the effects such as protection intestinal mucosa and fat-reducing.
Honeysuckle in the present invention is cold in nature, distinguishes the flavor of sweet, enters lung, the heart, stomach warp, has the effect that clearing heat and detoxicating, anti-inflammatory, qi-restoratives are treated wind, cures mainly disease under turgor, warm disease heating, the diseases such as hot malicious large carbuncle and tumour.It is dizzy for giddy, dry is done yearningly, the illnesss such as hidrosis is unhappy, enteritis, bacillary dysentery, measles, pneumonia, encephalitis, epidemic meningitis, acute mastitis, septicemia, appendicitis, skin infection, ulcer furunculosis, erysipelas, mumps, suppurative tonsillitis all have certain curative effect.Lonicera flower tea has unique weight losing function simultaneously, can also suppress and the pathogen of killing bottleneck throat, and old man and children are had to anti-infective effect.So, often take honeysuckle immersion or decoction and be conducive to wind fire hot eyes, abscess of throat, obesity, liver heat symptom-complex and the hypertensive treatment of liver pattern of fever and rehabilitation.Honeysuckle is containing inositol, flavonoids, inositol, saponin and tannin etc., there is broad-spectrum antibacterial action, the various pathogens such as staphylococcus aureus, shigella dysenteriae are all had to stronger inhibitory action, the multiple pathogenic microorganisms such as Leptospira, influenza virus and pathogenic moulds are also had to inhibitory action.In addition, honeysuckle also has obvious anti-inflammatory and refrigeration function, and honeysuckle water and steeping in wine liquid have obvious lethal effect to tentative tumour cell.
In the present invention, hawthorn is fruit, is again medicine, belongs to the medicine-food two-purpose article.Its main active substances has flavonoids (Quercetin, hyperin etc.), triterpenes (ursolic acid, oleanolic acid, crataegolic acid), chlorogenic acid, OPC (Procyanidins, be called for short PC, and two~tetramer is called for short OPC) etc.Hawthorn energy prevention and cure of cardiovascular disease, have hemangiectasis, increase CF, improve the heart vigor, the stimulating central nervous system system, reduce blood pressure and cholesterol, softening blood vessel and diuresis and sedation; Crataegolic acid also has cardiotonic, also helpful to senile heart disease; Hawthorn contains the fatty lipolytic enzyme of a kind of energy digestion, and more tartaric acid, contributes to food digestion, helps lend some impetus to especially the digestion of meat food; Hawthorn has inhibitory action to shigella dysenteriae, staphylococcus aureus, Pseudomonas aeruginosa; Hawthorn energy appetite-stimulating indigestion-relieving, offset carnivorous stagnant effect better especially, has the slimming and removing fat effect.Hawthorn has the effect activated blood circulation and dispersed blood clots, and contributes to remove local extravasated blood state, and traumatic injury is had to auxiliary curative effect.In addition, hawthorn has contraction to uterus, and the effect expedited the emergence of is arranged just before giving birth the time the pregnant woman.And can promote the uterine involution in postpartum.The generation of free radical is blocked and reduced to the flavonoids that hawthorn is contained and the substances such as vitamin C, carrotene, can strengthen the immunity of body, and anti-aging, anticancer effect is arranged.In hawthorn, having relievings asthma reduces phlegm, the composition of anti-bacteria, treatment abdominal pain diarrhea.The Tianjin IEM is measured the antioxidation activity of domestic common 30 kinds of fruit, and result shows the taking the first place of hawthorn anti-aging effects.Hawthorn has the merit of relieving the effect of alcohol and reducing phlegm, and pharmacological research proves, hawthorn can increase the gastric juice digestive ferment, promotes ethanol decomposition.The Vit C contents of hawthorn very high (89mg/100g) is 10 times of apple.Because hawthorn is rich in multiple organic acid, it can keep the vitamin C in hawthorn, even heating is also unlikely destroyed.The carotene carotene content of hawthorn is 9 times of apple, and vitamin B2 is 5 times of apple, and the content of calcium also comes out at the top in fresh fruit, also contains the nutriments such as a large amount of crataegolic acids, tartaric acid, malic acid, citric acid and protein, fat, starch.In hawthorn, the pectin content shelter has first of fruit, reaches 6.4%, and it has the effect of radio-opaque substance, in body, can be with the radioactive element (strontium, cobalt, palladium etc.) of walking half.Be rich in OPC in hawthorn, OPC has extremely strong antioxidation activity, is a kind of good free radical scavenger and lipid peroxidation inhibitor; And can harmful enzyme produce powerful inhibitory action, and there is antimutagenicity and anti-inflammatory activity, can treat the SH of rat and be dose-effect relationship, suppress platelet aggregation, reducing blood lipid, the effect such as antiviral, anticancer.
In sum, eucommia Bark male flower, mulberry leaf, honeysuckle, hawthorn have the functions such as hypotensive, reducing blood lipid, prevention cerebral thrombus and miocardial infarction that the effect direction is consistent, hypoglycemic, anti-ageing, antifatigue, enhancing immunity of organism.Therefore the stack of four flavor effects, have the compound synergistic effect; And long-pendingization that disappear of the filling liver kidney of eucommia Bark male flower and hawthorn is stagnant, tonifying spleen stomach strengthening function and the wind and heat dispersing of mulberry leaf, the function of clearing liver and improving vision reach again complementation, causes health care more outstanding.
The present invention adopts specific preparation method to be prepared into the form of beverage, and its characteristics have: 1. beverage is easy to absorption of human body, and drinks conveniently; 2. the amount of drinking is large, in its peculiar function of performance, also can supplement the moisture that human body needs; 3. the simple easy operating of technique, be beneficial to suitability for industrialized production, and can retain preferably the active ingredient in medicinal material; 4. it is drunk pattern and is easily accepted by the consumer, and compliance is good; 5. adopt the can packing, seal degree is good, and can adopt the sterilizing measure, is difficult for polluting again, is conducive to preserve.
Owing to having adopted technique scheme, the invention has the beneficial effects as follows:
Eucommia Bark male flower beverage provided by the invention, adopt eucommia Bark male flower, mulberry leaf, honeysuckle, four kinds of components of hawthorn, and there is the functions such as hypotensive, reducing blood lipid, prevention cerebral thrombus and miocardial infarction that the effect direction is consistent, hypoglycemic, anti-ageing, antifatigue, enhancing immunity of organism.Therefore the stack of four flavor effects, have the compound synergistic effect; And long-pendingization that disappear of the filling liver kidney of eucommia Bark male flower and hawthorn is stagnant, tonifying spleen stomach strengthening function and the wind and heat dispersing of mulberry leaf, the function of clearing liver and improving vision reach again complementation, cause antifatigue and strengthen the health care of immunity more outstanding.
And the inventor finds in experiment, when adopting eucommia Bark male flower, mulberry leaf, honeysuckle, hawthorn composition reasonably to arrange in pairs or groups, not only have antifatigue concurrently, strengthen the function such as immunity of organism, and two kinds of functions have obtained reinforcement to a certain degree, this is that inventor institute is not foresighted.This also illustrates, when eucommia Bark male flower, mulberry leaf, honeysuckle, hawthorn composition are reasonably arranged in pairs or groups, is not only the simple superposition of function, but has played joint action of potentiation, has each other complementation.
The specific embodiment
For technological means, creation characteristic that the present invention is realized, reach purpose and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
A kind of eucommia Bark male flower beverage comprises following raw material:
And adding man-hour, add steviol glycoside 0.3g, thereby prepare Sugarless type eucommia Bark male flower beverage.
The detailed step of preparation is as follows:
S1, weighing 4g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 6g honeysuckle, 8g mulberry leaf and 5g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein steviol glycoside 0.3g, stir evenly, add purified water to gross weight 1000g.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain Sugarless type eucommia Bark male flower beverage.
Embodiment 2
A kind of eucommia Bark male flower beverage comprises following raw material:
And adding man-hour, add steviol glycoside 0.4g, thereby prepare Sugarless type eucommia Bark male flower beverage.
The detailed step of preparation is as follows:
S1, weighing 6g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 8g honeysuckle, 6g mulberry leaf and 3g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein steviol glycoside 0.5g, stir evenly, add purified water to gross weight 1000g.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain the eucommia Bark male flower beverage.
Embodiment 3
A kind of eucommia Bark male flower beverage comprises following raw material:
And adding man-hour, add steviol glycoside 0.3g, thereby prepare Sugarless type eucommia Bark male flower beverage.
Detailed preparation process is as follows:
S1, weighing 5g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 7g honeysuckle, 7g mulberry leaf and 4g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein steviol glycoside 0.4g, stir evenly, add purified water to gross weight 1000g.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain the eucommia Bark male flower beverage.
Embodiment 4
A kind of eucommia Bark male flower beverage comprises following raw material:
And, adding man-hour, add white granulated sugar, and the 7wt% that described white sugar content is eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, thus make sugar-containing type eucommia Bark male flower beverage.
Detailed preparation method is as follows:
S1, weighing 6g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 8g honeysuckle, 8g mulberry leaf and 5g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein the 7wt% that white granulated sugar, described white sugar content are eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, stir evenly, add purified water to gross weight 1000g.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain the eucommia Bark male flower beverage.
Embodiment 5
A kind of eucommia Bark male flower beverage comprises following raw material:
And work in-process, add white granulated sugar, the 5wt% that described white sugar content is eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, thus make sugar-containing type eucommia Bark male flower beverage.
Detailed preparation method is as follows:
S1, weighing 4g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 6g honeysuckle, 6g mulberry leaf and 3g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein the 5wt% that white granulated sugar, described white sugar content are eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, stir evenly, add purified water to gross weight 1000g.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain the eucommia Bark male flower beverage.
Embodiment 6
A kind of eucommia Bark male flower beverage comprises following raw material:
And, adding man-hour, add white granulated sugar, and the 6wt% that described white sugar content is eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, thus make sugar-containing type eucommia Bark male flower beverage.
The preparation method is as follows in detail:
S1, weighing 5g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 7g honeysuckle, 7g mulberry leaf and 4g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein the 6wt% that white granulated sugar, described white sugar content are eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, stir evenly, add purified water to gross weight 1000g.
Then beverage is filtered, embedding, sterilizing, check, packing, obtain the eucommia Bark male flower beverage.
Embodiment 7
The selection of flavouring.In order to make product there is good mouthfeel when drinking, improve the drinking person compliance, therefore add flavouring, improved.Consider that the consumer groups such as diabetes, obesity also can drink this product, therefore Sugarless type eucommia Bark male flower beverage selects steviol glycoside to regulate mouthfeel.
Method:
Weighing 25g eucommia Bark male flower, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract; Weighing 35g honeysuckle, 35g mulberry leaf and 20g hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate; Above-mentioned liquid is merged, be divided into 5 parts, add respectively the steviol glycoside of different proportion, and add purified water to gross weight 1000g.
Mouthfeel is investigated, be the results are shown in Table 1.
Table 1: flavouring is investigated situation
While as can be seen from Table 1, in 1000g solution, containing the 0.3-0.4g steviol glycoside, sugariness is moderate.0.5g if, mouthfeel is sweeter greasy, is not suitable as the Sugarless type beverage.
Embodiment 8
Eucommia Bark male flower beverage provided by the invention strengthens the research to immunity, anti-fatigue performance
Method:
By a mouse, random even minute in blank group, eucommia Bark male flower folk prescription group, honeysuckle folk prescription group, mulberry leaf folk prescription group, hawthorn folk prescription group and eucommia Bark male flower beverage group.
Eucommia Bark male flower folk prescription group: weighing 5g eucommia Bark male flower, ultrasonic wave extracts, then adds purified water to gross weight 1000g.
Honeysuckle folk prescription group: weighing 7g honeysuckle, boiling twice adds the water of 14 times of amounts of honeysuckle at every turn, and each decocts 1 hour, extracts filtrate filtration, then adds purified water to gross weight 1000g.
Mulberry leaf folk prescription group: weighing 7g mulberry leaf, boiling twice, the water of each 14 times of amounts of mulberry leaf weight, each decocts 1 hour, extracts filtrate filtration, then adds purified water to gross weight 1000g.
Hawthorn folk prescription group: weighing 4g hawthorn, boiling twice adds the water of 14 times of amounts of hawthorn weight at every turn, and each decocts 1 hour, extracts filtrate filtration, then adds purified water to gross weight 1000g.
Eucommia Bark male flower beverage group: the beverage that adopts embodiment 2 preparations.
The grouping of table 2 experimental animal
Sequence number | Group | Quantity | Dosage |
1 | The blank group | 20 | Physiological saline, every day, gavage 500g, divided 2 times |
2 | Eucommia Bark male flower folk prescription group | 20 | Every day, gavage 250g, divided 2 times |
3 | Honeysuckle folk prescription group | 20 | Every day, gavage 250g, divided 2 times |
4 | Mulberry leaf folk prescription group | 20 | Every day, gavage 250g, divided 2 times |
5 | Hawthorn folk prescription group | 20 | Every day, gavage 250g, divided 2 times |
6 | Eucommia Bark male flower beverage group | 20 | Every day, gavage 250g, divided 2 times |
According to the dosed administration in table 2.Then every group mouse is divided at random to 2 groups (10 one groups) and carries out respectively immunity mensuration and anti-fatigue test.
Immunity is measured:
The t lymphocyte subset group is the important cells that forms the immunity of organism system of defense.Modern immunology viewpoint is thought, the number of T cell subsets and CD4 in peripheral blood
+/ CD8
+ratio is one of parameter of estimating the optimum meaning of Organism immunoregulation poised state, and therefore, the present embodiment selects this index as immunity is measured.
After successive administration 7 days, get peripheral blood and detected with flow cytometer, statistics is as table 2, and in table 2, numerical value is mean value.
Table 2
Sequence number | Group | CD4 +(%) | CD8 +(%) | CD4 +/CD8 + |
1 | The blank group | 44.95 | 20.43 | 2.20 |
2 | Eucommia Bark male flower folk prescription group | 56.86 | 15.38 | 3.70 |
3 | Honeysuckle folk prescription group | 51.91 | 19.87 | 2.61 |
4 | Mulberry leaf folk prescription group | 49.12 | 19.91 | 2.47 |
5 | Hawthorn folk prescription group | 45.24 | 20.33 | 2.23 |
6 | Eucommia Bark male flower beverage group | 64.57 | 13.10 | 4.93 |
From table 2, with the blank group, to compare, all the other experimental group all can improve CD4
+/ CD8
+ratio.Wherein, eucommia Bark male flower folk prescription group, honeysuckle folk prescription group promote larger, although and mulberry leaf folk prescription group, hawthorn folk prescription group are improved, amplitude is little.And eucommia Bark male flower beverage group provided by the invention can greatly improve CD4
+/ CD8
+ratio.
After successive administration 20 days, measure antibody-producting cell number in spleen.Statistics is as table 3, and in table 3, numerical value is mean value.
Table 3
Sequence number | Group | Antibody-producting cell number/10 6 |
1 | The blank group | 195.07 |
2 | Eucommia Bark male flower folk prescription group | 208.41 |
3 | Honeysuckle folk prescription group | 212.53 |
4 | Mulberry leaf folk prescription group | 198.37 |
5 | Hawthorn folk prescription group | 196.01 |
6 | Eucommia Bark male flower beverage group | 381.43 |
From table 3, with the blank group, compare, except mulberry leaf folk prescription group, hawthorn folk prescription group antagonist cellulation number improve not quite, eucommia Bark male flower folk prescription group, honeysuckle folk prescription group and eucommia Bark male flower beverage group antagonist cellulation number have obvious raising, and the raising of eucommia Bark male flower beverage group antagonist cellulation number especially provided by the invention has very significant effect.
Therefore, eucommia Bark male flower beverage composition minute provided by the invention plays good joint action of potentiation, has greatly improved CD4
+/ CD8
+ratio and antibody-producting cell number, can improve immunity of organisms.
Anti-fatigue test
Successive administration 5 days, after last administration 1 hour, after bearing a heavy burden (body weight 10%), mouse tail drops into the water went swimming of 25 ℃, observe and record mouse and within 7 seconds, can not swim out of the time of the water surface as the swimming exhaustion time from dropping in water to the head submerged, statistics is as table 4, and the data in table 4 are mean value.
Table 4
Sequence number | Group | The swimming exhaustion time (min) |
1 | The blank group | 15.24 |
2 | Eucommia Bark male flower folk prescription group | 23.43 |
3 | Honeysuckle folk prescription group | 17.30 |
4 | Mulberry leaf folk prescription group | 24.51 |
5 | Hawthorn folk prescription group | 15.74 |
6 | Eucommia Bark male flower beverage group | 28.76 |
From table 3, with the blank group, compare, except hawthorn folk prescription group is little to the raising of swimming exhaustion time, eucommia Bark male flower folk prescription group, honeysuckle folk prescription group, mulberry leaf folk prescription group, eucommia Bark male flower beverage group all have raising in various degree to the swimming exhaustion time.Especially eucommia Bark male flower beverage group provided by the invention has very significant effect to the raising of swimming exhaustion time.
Therefore, eucommia Bark male flower beverage composition minute provided by the invention plays good joint action of potentiation, and the time is exhausted in the swimming that has greatly extended mouse, can improve the anti-fatigue performance of body.
The present invention is not limited to the above-mentioned specific embodiment, and all are based on technical conceive of the present invention, and the structural improvement of having done, all fall among protection scope of the present invention.
Claims (6)
3. a kind of eucommia Bark male flower beverage as claimed in claim 1 or 2, is characterized in that: add steviol glycoside 0.3~0.4 weight portion in described eucommia Bark male flower beverage, thereby prepare Sugarless type eucommia Bark male flower beverage.
4. a kind of eucommia Bark male flower beverage as claimed in claim 1 or 2, it is characterized in that: in described eucommia Bark male flower beverage, add white granulated sugar, 5wt%~7wt% that described white sugar content is eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight, thus make sugar-containing type eucommia Bark male flower beverage.
5. a kind of eucommia Bark male flower beverage as claimed in claim 3, it is characterized in that: the preparation method is as follows:
S1, weighing 4~6 weight portion eucommia Bark male flowers, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 6~8 weight portion honeysuckles, 6~8 weight portion mulberry leaf and 3~5 weight portion hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then add wherein steviol glycoside 0.3~0.4 weight portion to stir evenly, add purified water to gross weight 1000 weight portions.
6. a kind of eucommia Bark male flower beverage as claimed in claim 4, it is characterized in that: the preparation method is as follows:
S1, weighing 4~6 weight portion eucommia Bark male flowers, and utilize ultrasonic wave to extract, obtain the ultrasonic wave extract;
S2, weighing 6~8 weight portion honeysuckles, 6~8 weight portion mulberry leaf and 3~5 weight portion hawthorn, boiling twice adds the water of honeysuckle, mulberry leaf and 14 times of amounts of hawthorn gross weight at every turn, and each decocts 1 hour, extracts filtrate filtration, merging filtrate;
S3, the liquid in step S1 and S2 is merged, then adds wherein 5wt%~7wt% that white granulated sugar, described white sugar content are eucommia Bark male flower, honeysuckle, mulberry leaf and hawthorn gross weight,, add purified water to gross weight 1000 weight portions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310468954.0A CN103478820A (en) | 2013-10-08 | 2013-10-08 | Eucommia male flower beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310468954.0A CN103478820A (en) | 2013-10-08 | 2013-10-08 | Eucommia male flower beverage |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103478820A true CN103478820A (en) | 2014-01-01 |
Family
ID=49819681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310468954.0A Pending CN103478820A (en) | 2013-10-08 | 2013-10-08 | Eucommia male flower beverage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103478820A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105614800A (en) * | 2015-12-22 | 2016-06-01 | 陕西今正蜂业有限公司 | Eucommia ulmoides male flower honey and preparation technology thereof |
CN105961962A (en) * | 2016-03-22 | 2016-09-28 | 安徽培林食品科技有限公司 | Honey peach sports drink |
CN108324746A (en) * | 2018-05-02 | 2018-07-27 | 冯显春 | A kind of medicine materical crude slice and preparation method thereof that preventives treatment of disease made of Cordyceps militaris and eucommia Bark male flower |
CN108713746A (en) * | 2018-05-31 | 2018-10-30 | 南京中生生物科技有限公司 | A kind of integration of drinking and medicinal herbs composition and its preparation method and application |
CN110150389A (en) * | 2019-05-30 | 2019-08-23 | 成都中医药大学 | A kind of eucommia Bark male flower Manufacture of Walnut Milk and its preparation method and application |
CN110680850A (en) * | 2019-12-02 | 2020-01-14 | 黑龙江中医药大学 | Traditional Chinese medicine health product for reducing blood fat |
CN112205559A (en) * | 2020-10-20 | 2021-01-12 | 山东贝隆杜仲生物工程有限公司 | Composition containing eucommia ulmoides and mulberry leaves and application |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020003165A (en) * | 2001-11-23 | 2002-01-10 | 송윤강 | Process for Producing a fermented food for health aid |
CN101223928A (en) * | 2008-01-29 | 2008-07-23 | 张康健 | Eucommia Bark male flower instant tea and preparing method thereof |
CN101322572A (en) * | 2008-07-21 | 2008-12-17 | 西北农林科技大学 | Bark of eucommia and mulberry leaf drink and preparation thereof |
CN101919566A (en) * | 2010-02-25 | 2010-12-22 | 程辰 | Eucommia bark and honeysuckle beverage for good health and long life and preparation method |
CN102919473A (en) * | 2012-11-20 | 2013-02-13 | 国家林业局泡桐研究开发中心 | Eucommia staminate flower tea beverage and processing method thereof |
-
2013
- 2013-10-08 CN CN201310468954.0A patent/CN103478820A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020003165A (en) * | 2001-11-23 | 2002-01-10 | 송윤강 | Process for Producing a fermented food for health aid |
CN101223928A (en) * | 2008-01-29 | 2008-07-23 | 张康健 | Eucommia Bark male flower instant tea and preparing method thereof |
CN101322572A (en) * | 2008-07-21 | 2008-12-17 | 西北农林科技大学 | Bark of eucommia and mulberry leaf drink and preparation thereof |
CN101919566A (en) * | 2010-02-25 | 2010-12-22 | 程辰 | Eucommia bark and honeysuckle beverage for good health and long life and preparation method |
CN102919473A (en) * | 2012-11-20 | 2013-02-13 | 国家林业局泡桐研究开发中心 | Eucommia staminate flower tea beverage and processing method thereof |
Non-Patent Citations (1)
Title |
---|
田建华,等: "《豆浆茶饮养生宝典》", 30 April 2012 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105614800A (en) * | 2015-12-22 | 2016-06-01 | 陕西今正蜂业有限公司 | Eucommia ulmoides male flower honey and preparation technology thereof |
CN105961962A (en) * | 2016-03-22 | 2016-09-28 | 安徽培林食品科技有限公司 | Honey peach sports drink |
CN108324746A (en) * | 2018-05-02 | 2018-07-27 | 冯显春 | A kind of medicine materical crude slice and preparation method thereof that preventives treatment of disease made of Cordyceps militaris and eucommia Bark male flower |
CN108713746A (en) * | 2018-05-31 | 2018-10-30 | 南京中生生物科技有限公司 | A kind of integration of drinking and medicinal herbs composition and its preparation method and application |
CN110150389A (en) * | 2019-05-30 | 2019-08-23 | 成都中医药大学 | A kind of eucommia Bark male flower Manufacture of Walnut Milk and its preparation method and application |
CN110680850A (en) * | 2019-12-02 | 2020-01-14 | 黑龙江中医药大学 | Traditional Chinese medicine health product for reducing blood fat |
CN112205559A (en) * | 2020-10-20 | 2021-01-12 | 山东贝隆杜仲生物工程有限公司 | Composition containing eucommia ulmoides and mulberry leaves and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101090284B1 (en) | Tonic comprising red ginseng and deer antlers extracts and manufacturing method thereof | |
CN103478820A (en) | Eucommia male flower beverage | |
CN104872504A (en) | Meal-replacing powder capable of replacing daily diet and having balanced nutrition and preparation method of meal-replacing powder | |
CN103463457B (en) | Composite chewable tablet of Herba Dendrobii Hericium erinaceus (Bull. Ex Fr.) Pers. and preparation method thereof | |
CN105455047A (en) | Health carp ball and making method thereof | |
KR101018065B1 (en) | Method for manufacturing health drink using jujube leaf and health drink manufactured by this | |
CN102987477B (en) | Health drink | |
CN107156828A (en) | A kind of full nutrition formula food suitable for patients with inflammatory bowel | |
CN108719984A (en) | A kind of generation meal nutrition bar and preparation method thereof for gout crowd | |
KR20150040392A (en) | undiluted stevia liquid and the berages, and its manufacturing method | |
CN105901452A (en) | Tartary buckwheat beverage and preparation method thereof | |
KR101722481B1 (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
CN106070626A (en) | Koumiss fruit beverage and preparation method thereof | |
KR101632794B1 (en) | METHOD OF MANUFACTURING PILL COMPRISED OF Protaetia brevitarsis seulensis | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
CN113855766A (en) | Gingko and cordyceps militaris granules capable of regulating blood pressure | |
CN103695275B (en) | Method for preparing Korean-ginseng and sea cucumber wine | |
KR101122586B1 (en) | Hang over beverage containing freeze-dring Abalone flesh and It's manufacturing method | |
KR20140082015A (en) | Wood-cultivated ginseng Kyoung-ok-ko and method for preparing the same | |
CN101955874B (en) | Method for brewing bitter almond liqueur | |
CN102293290B (en) | Tea capable of digesting and smoothing intestine and preparation method thereof | |
CN105249475A (en) | Health care alga agar-agar jelly and preparation method of health care alga agar-agar jelly | |
CN105981853A (en) | Nutritional function enriched mild warm tea drink recipe | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
CN106616099A (en) | Health-care beverage capable of improving appetite of children and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140101 |